Clinical evaluation of therapeutic success in rabbits with suspected encephalitozoonosis.
Between 2000 and 2008, 95 rabbits with suspected encephalitozoonosis and neurological symptoms were treated at the Clinic of Small Animal Medicine, Ludwig Maximilian University Munich. Standard treatment consisted of oxytetracycline (from 2000 to 2003; n=50) or fenbendazole and oxytetracycline (from 2004 to 2008; n=45), and the rabbits were randomly assigned to treatment groups with or without dexamethasone. Each therapeutic regime was given for 10 days, with fluids, B vitamins and nutritional support added as needed. Therapeutic success was evaluated by assessing the survival rate on day 10, the neurological score of the surviving rabbits and Kaplan-Meier curves for long-term survival past 10 days. Inclusion of fenbendazole in the treatment protocol was associated with increased survival rates on day 10 (p=0.043), better neurological scores (p=0.008), and improved long-term survival (p=0.025) based on the results of univariate analyses. Treatment with dexamethasone showed no effect on neurological score or on short- or long-term survival. The study did not provide any evidence that dexamethasone is an effective component of the treatment scheme.
Clinic of Small Animal Medicine Department of Veterinary Clinical Sciences, Ludwig Maximilians University Munich, Veterinärstr. 13, 80539 Munich, Germany.
Jessica
J
Sieg
Jutta
J
Hein
Ariane
A
Jass
Carola
C
Sauter-Louis
Katrin
K
Hartmann
Andrea
A
Fischer
D000818:Animals; D000935:Antifungal Agents / Q000627:therapeutic use; D016890:Encephalitozoonosis / Q000188:drug therapy / Q000662:veterinary*; D005260:Female; D005273:Fenbendazole / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D010118:Oxytetracycline / Q000008:administration & dosage / Q000627:therapeutic use*; D011817:Rabbits; D013997:Time Factors
D000935:Antifungal Agents; D005273:Fenbendazole; D010118:Oxytetracycline